GE Healthcare

1 GE HealthcareINVESTOR UPDATEM arch 11, 2016 New York City1 Caution Concerning Forward-Looking Statements:This document contains "forward-looking statements" that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain. For details on the uncertainties that may cause our actual future results to be materially different than those expressed in our forward-looking statements, see well as our annual reports on Form 10-K and quarterly reports on Form 10-Q. We do not undertake to update our forward-looking statements. This document also includes certain forward-looking projected financial information that is based on current estimates and forecasts. Actual results could differ is GE HealthcareIMPACTAT SCALER evenue $18 BOp Profit $ Conv. 126%Leader in Imaging 1MM+ Installed Base 16K+ Scans every minuteLeader in Life Sciences Presence in biologicsLeader in Data & Analytics 230MM exams; 124K assets under managementLeader in China & Emerging Markets2GE Healthcare in contextBig opportunity $7T global market-~10% of global GDP Core long term growth-Aging demographics-Chronic disease-Emerging market access Critical infrastructure-Lynchpin of economy-Politically important $3T market cap-12%+ of equity marketGE store Leverages and enhances brand Opens doors around the world Digital platform Industrial know how -Cost out TechnologyEssential global industry.

2 Strong GE fit3A leading Healthcare solutions provider4$8B$4B$2B$4 BDiagnosticimaging & serviceMobile diagnostics & monitoringIT &digital solutionsLife SciencesMagnetic ResonanceUltrasoundEnterpriseImagingBiop rocessComputed TomographyClinicalSolutionsFinancial ManagementProtein & CellSciencesMolecular ImagingMonitoringCare AreaW orkflowsContrast Media & NuclearTracersService & SolutionsMobileHealthGE Health CloudTMCellular TherapyHistory and path forward5$18B$ ProfitFCFC onversion Slow growth (Last 5 Yrs) Government funding pressures US market uncertainty (ACA) FX headwind Underachieved on cost Running business better-Differentiated customer experience-Product costs down / restructuring-Invest in core imaging-Leverage Ultrasound playbook High return organic growth opportunities-Ultrasound-Emerging markets-Life Sciences Grow Digital / Solutions-GE Health Cloud New leadership team + AEIP alignmentFinancials ($B)Path forwardDriving growth and returnsAccelerating shift towards value-based healthcareIndustry forcesSystemic reactionsNew paradigms of careBurden of COSTE xplosion of DATAR etail PharmacyDx Imaging CenterPhysician ClinicIn-patient RehabCardiologyOROncologyCommunity-Based Care.

3 Moving to clinicAcute .. care-area focusedPost-Acute Care .. moving to mobile healthPreventive CareRadiologyOut-patientRehabHospitalHom e CareGOV T POLICYE nabling the value agendaCONSUMERSBear more risk, demand valueDIGITIZATIONS ystem-wide connectivity to enable value deliveryNEW ENTRANTSC reating disruptive models to capture new profit poolsCustomers need solutions for value-based and personalized care6 MOBILITYGE Healthcare Leading provider of outcome-based solutions in healthcare7GE HealthcareStrategic prioritiesMargin expansionSourcing at scale, brilliant/lean factories, digital servicesW orld-class imagingDistributed imaging .. aligned to market needsLeader in market solutionsGE as partner of choice to grow access to affordable careExpand Life SciencesEnable next generation of therapies & pharma productivityDigital growthMobile & cloud-based apps, product & system-wide solutionsOp Profit$ ++$ ++/++'15'16E'17F+($ in billions)Revenue8 Cash & capital allocationRigorous cash mgmt& disciplined capital controls123456 BrilliantFactories5 60 ERPs48 4 VCP Invest$150-200 DualSources28% 50%ServiceMarginUp 2 ptsMargin expansion'13'14'15'16E'18 FKey driversDesign productivity Engineering focus on material cost out.

4 2X Investment Launch NPIs with expanded CM ratesLowest cost procurement, manufacturing & assembly Global best-cost country sourcing, reduced cost of quality Global supply chain .. lean, digital thread & brilliant factoriesServices margin accretion Grow value-added software-enabled offerings Increase material and labor productivityStructural simplification Increasing shared service penetration, single ERP Localize engineering/software, reduce spans/layersPoised for 3X historical cost ~ +~18% +91Op Margin %MetricsWorld-class imagingMatching product development with market needsIMAGINGULTRASOUND10 Market-backed new product introduction Care area and value-based segmentationis key Accretive margins across the value chain Women s health Voluson$25-150kCardiacVivid $25-200kGeneral imagingLOGIQ $25-200kPrimary care Vscan$7-25kAvgSelling PriceInterventional Cardiology & RadiologySurgeryWomen s HealthSurgical C-Arms~$20-200 KImage Guided Systems~$ ~$100k-500kLunar ~$20k-200kGeneral ImagingMolecular ImagingRevolution CT~$ ~$ MR~$ in market solutionsDiverse markets.

5 Customized approachDeveloped markets ~75%Emerging markets ~25% company-to-country focus Aligned with MOH priorities Select localization in key regionsSolid path to growth Expand coverage & service Mfg. localization in Brazil Introducing disruptive NPI Private driven .. low govt. funding Local R&D teams drive innovationBuilding a $5B business Local capabilities on par w/ & EU Global COE for value productsAccelerate growth to meet demand Countries investing in HC systems Expand coverage & svc. capability ACA uncertainty diminishing .. growth returning 15 16E$ +Revenue Focus on outcomes .. opportunity exists in solutions, ex. Temple University Health System Solid growth in Europe platform-6consecutive quarters of organic orders growth-Eastern Europe double digit growthRev Growth: 09 15311GE Healthcare in ChinaChina still very increasing spend from to of GDP by 2020 Revenue Strong commercial presence-1,500+ direct sales 60% deployed in Tier 2 & 3 cities -Dedicated sales managers to support private growth-Differentiated service offerings Value COE.

6 For China and the world-1,000+ engineers .. full system design-36 China NPI s launched .. $1B+ rev. (35% China, 65% ROW) Service .. 70%+ parts local repair -1 local repair shop + 3 tier parts distribution .. 40% remote fix Supply chain .. 2X output-1 of every 2 GE CT s shipped from Beijing, 1 of 3 GE Ultrasound devices shipped from Wuxi, new MR plant Strong Life Sciences: first 2 global KUBiodeals signedTenders .. Market bottoming out 05 10 15$ $ $ ($ in billions)(YoYChange %)Q3 14Q4 14Q1 15Q2 15Q3 15Q4 15-14%-13%-8%-7%-6%1%=/+ 16++PublicPrivateStrong local presence122015 financialsExpand Life Sciences'15'16E$4 BCritical solutions for biopharmaceutical companies Creates flexible, productive capacity Highly regulated production process Equipment + consumables business modelStrong organic growth opportunities Strong top line Bioprocess 10%+ Turnkey investments with 20%+ returns Leading partner in emerging field of cell therapyLeverages GE s strengths GRC.

7 Product pipeline Growth markets .. China Services GE know how M&A leverages GE footprint / brand W ing-to-wing offeringChromatographyMedia & EquipmentBio-Reactorsfor cell growthCell CultureMedia & Sera++Software and Services20% + Margins$1B+ FCF13 Revenue++$4 BRobust business model with high returns4 Digital growth14 15~$2B+Deep installed base/customer relationships+Leader in Radiology imaging+Gaining share in enterprise imaging & financial management Multiple platformsPath forwardImproving customer productivity & patient outcomesRevenuesCloud: ++Existing: = 16+ Software business Build on deep clinical domain expertise Standardize on Predix Internal Digitization Digital thread .. Brilliant factories Service efficiency Engineering/design tools GE Health Cloud Mobility/collaboration Analytics .. GE + 3rdparties Aggregated images & data outcomes5 ApplicationsPlatformMobility supportHealth data mgmtMulti modalityInter-operabilityPrivacyScalabil itySecurityPaaSInfrastructure ServicesDeployment & ServiceDiagnostic imagingCellular diagnosisThousands of applications from Independent Software VendorsUltrasoundMonitoringAsset performance Dose managementOperational analyticsDrug develop mtEnterprise imagingFinancial managementPopulation Health(Caradigm)

8 Care area workflowsWorkforce managementGE Healthcare appsISV appsGE Health Cloud servicesVisualizationGuideline & protocolsCare pathway modelingWorkflowCare navigationCare coordinationCollaborationAnalytic model developmentData science & decision supportAnalyticsGE Predix servicesGE advantageGE Digital portfolio15 Installed base Customer relationships Clinical expertise Secure platform FDA/regulatory GE StoreCash & capital allocation16 Capital allocationDisciplined capital producing strong returns for investorsStrong cash conversion Disciplined investing based on ROIC, differentiated R&D Driven by cost-out & working capital M&A targets bolt on to existing franchise, risk Portfolio pruning: exit low ROIC businesses, ex. Clarient Disciplined capex and WC management Capex: average investment ~ year payback Inventory: Targeting 1 turn factory improvements A/P: +2 day .. harmonizing terms across GE 13 14 15106%100%126%% of NI 16E+2 Cash Flow6 Today s agendaGE Healthcare9 AM 11 AM Business OverviewImaging & ServicesSupply Chain ExcellenceMobile Diagnostics & MonitoringEmerging MarketsQ&AJohn FlanneryKarim Karti, ImagingChuck Nugent, Global Supply ChainAnders W old, UltrasoundTerri Bresenham, Sustainable Healthcare SolutionsTeamLife Sciences Kieran Murphy, Life SciencesDeliveringJohn FlanneryProduct showcase11 AM 12 PM17 Digital GrowthDavid Hale, DigitalMobile diagnostics and monitoringUltrasound: Built on strong product managementBuilt on strong historySolid market fundamentals & GE growth ~2x marketGuiding principles: Customer backed R&D.

9 Optimizes success in market , Premium to Value in all care settings Fast innovation .. >10 NPI s every year, embedded in winning culture Product cost out .. (10)%/year, non-negotiable, aligned with technology curve2015 financials 95 05 15$1B$2 BRevenue$ '1516E$4 BRevenue++$2B19 GE Ultrasound technology leaderVOLUSONW omen s healthLOGIQG eneral imagingVIVIDC ardiovascularReal time PortableImage qualityEasy to useLower costHigh technology segmented to new users & new applications20 Ultrasound entering new markets for GEHC2119952015199520152015 Improving quality , cost, use in all out of hospital to clinicsGolden rule: Annual NPI s & cost out on every product release, extensive use of cost catalogUltrasound growing gross CultureOne Team Cost Productivity is Priority 1 New Product LaunchesRegular Platform RefreshesDrive Innovation & Cost Out Existing Product FocusShared Goal of Cost Out Weekly RigorNPI Price uplift10% cost Every product, every year FastWorks principles guide NPI s Sourcing.

10 Input cost Value engineering & design quality & reliability forefrontDriving marginaccretionCulture drives margin accretion Template for Imaging business10%+7 (CAGR)MarginAgainst 10% price erosion2010 -201522GE Ultrasound growthFinancials23 Key drivers of growthCore General imaging, women s health, cardiacNew UsersClinic, point of care, servicesNew profit poolsPrimary care, distributed health, guidanceDATACONNECTED SOLUTIONSS ales($ billions) 15 20F2 XGrowth~$2B~$4B+Investments:Sales++R&D++ Manuf.+~4-6%~3-5%~1-3%Driving ~2X growth by 2020 Miniaturization&wireless(GRC)Sensors & monitors (GRC)Mobile monitoring24 The problemGE innovationsSolutionsCloud & analytics(Predix )Customer issues-Too many wires-Risk of infection-Periodic measurement-Reactionary-Reduce cost of careGE value-add-Miniaturization & sensor technology-Real-time monitoring in Cloud leveraging Predix secure, robust-Proactive, linked to clinical care apps++ $800MM monitoring business, growing double-digit Leveraging GE store to lead key industry trend High margins, accretive to businessSee tutorial regarding confidentiality disclosures.